Dextromethorphan Hydrobromide/Carbocistein/Pseudoephedrine Hydrochloride

氢溴酸右美沙芬/羧甲司坦/盐酸伪麻黄碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDextromethorphan Hydrobromide/Carbocistein/Pseudoephedrine Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsAlpha adrenergic receptor agonists
TargetsGlutamate [NMDA] receptorAlpha adrenergic receptor
Therapy Area/IndicationsCommon Cold
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Dextromethorphan HydrobromideCarbocysteinePseudoephedrine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A